Atlas Trials

FengYan Jin

5 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch FengYan Jin

RecordFirmDate
Risk-adapted Therapeutic Strategy in +1q NDMM (NCT07045168)FengYan Jin2025-09-15
Dara-PD in the Treatment of Patients With First Relapse of Multiple Myeloma (NCT06252792)FengYan Jin2023-06-15
Rituximab, Methotrexate, and Tepadina Induction Followed by Etoposide and Cytarabine Consolidation in Primary Central Nervous System Lymphoma (NCT06946407)FengYan Jin2022-12-02
A Perspective Study of the MRD-tailored Therapy in Patients With Newly Diagnosed Multiple Myeloma With Persistent Minimal Residual Disease After Initial Treatment (NCT06109233)FengYan Jin2022-01-10
Individualized Dynamic Frailty-tailored Therapy (DynaFiT) in Elderly Patients With NDMM (NCT06099912)FengYan Jin2021-09-08

Track FengYan Jin automatically

Every clearance here is in the API, with alerts when new ones post.